Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention - Top-Institutions - MDSpire

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention

  • By

  • Shuyun Jiang

  • Zhanwei Du

  • Yufei Wang

  • Hongwei Ma

  • Zhijun Ma

  • Xiaowang Wang

  • May 14, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #2

    Translational Breast Cancer Research Consortium
    Translational Breast Cancer Research Consortium

    N/A, N/A

    Key Differentiators

    • Oncology

  • #3

    European Society of Cardiology
    European Society of Cardiology

    N/A, N/A

    Key Differentiators

    • Cardiology

  • #4

    CARDIOCARE
    CARDIOCARE

    N/A, N/A

    Key Differentiators

    • Cardiology

  • #5

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention

  • by Shuyun Jiang, Zhanwei Du, Yufei Wang, Hongwei Ma, Zhijun Ma, Xiaowang Wang

  • May 14, 2026

Related Content

Spatial organization of the tumor immune microenvironment in LAR+ triple-negative breast cancer

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
25HC regulates the polarization of CD163+ macrophages in the immune microenvironment of triple-negative breast cancer through the interferon pathway